We have demonstrated that, at least in one well-controlled patient, with a manicdepressive illness with an unusual but precise 48h rhythm, the process could be stopped and re-started by altering the Li+/Naf ratio of the diet (Hanna et a/., 1972) . Treatment was effective after 18 years of severe illness, and for 4 years the patient remained well; nevertheless the 48 h rhythm of illness returned when lithium salt was replaced by a placebo, as was shown in his mood, his urine volume, salivation rate etc. Following this, the work of the Medical Research Council Unit for Metabolic Studies in Psychiatry included studies of the physical erects of lithium salts. The clinical results, though striking, are simply a confirmation of other studies (e.g Coppen et al., 1971; Baastrup et al., 1970) .
Biochemical Studies on the Effects of Lithium Salts: Excretion of Tricarboxylic Acid-Cycle Intermediary Metabolites, Inhibition of Vasopressin and Distribution of other Ions in the Body
We have demonstrated that, at least in one well-controlled patient, with a manicdepressive illness with an unusual but precise 48h rhythm, the process could be stopped and re-started by altering the Li+/Naf ratio of the diet (Hanna et a/., 1972) . Treatment was effective after 18 years of severe illness, and for 4 years the patient remained well; nevertheless the 48 h rhythm of illness returned when lithium salt was replaced by a placebo, as was shown in his mood, his urine volume, salivation rate etc. Following this, the work of the Medical Research Council Unit for Metabolic Studies in Psychiatry included studies of the physical erects of lithium salts. The clinical results, though striking, are simply a confirmation of other studies (e.g Coppen et al., 1971; Baastrup et al., 1970) .
Since these studies our work on the effects of treatment with lithium salts has been directed in several directions, including studies of the effects of the treatment on: (i) the excretion of organic acids and particularly tricarboxylic acid-cycle intermediates; (ii) the action ofvasopressin; (iii) the redistribution of other ions in the body; (iv) the resting and the sleeping electroencephalogram ; (v) urine amines and steroids. Some findings on (i)-(iv) are presented here.
Excretion of organic acids
Bond et al. (1972) demonstrated that lithium salts in therapeutic doses increase the renal excretion of 2-oxoglutarate and glutarate, but not of citrate, pyruvate or lactate, in both normal and manic-depressive men. The fact that increased 2-oxoglutarate excretion is not accompanied by increased citrate excretion (as can be produced by NaHC03) shows that the phenomenon is not a simple response to the alkaline urine produced by the administration of lithium salts. The titratable acidity of urine, however, does fall on the first day of therapy with lithium salts. This is largely due to an increased excretion of HC03-ions. Almost identical responses are given by LiCl and by Li2C03, but it is necessary to give more than 6mequiv. of Li' twice a day to detect a clear effect in 24h urine samples. All persons studied with the usual clinical doses of 18-36mequiv. of Li+/day for the carbonate, giving plasma concentrations of approx. 0.5-1.5 mequiv./I, showed quite clear responses. There was, however, much variation in the timing of the response and of the amplitudes achieved. The amount of 2-oxoglutarate lost increases slowly over several months of treatment, but nevertheless bears a close relationship during the day to the amount of Li+ also excreted, and on cessation of treatment both fall together with a somewhat similar timing.
In contrast, excretion of HC03-is raised only on the first day of treatment; on a controlled diet it subsequently returns to control values, but on the day after cessation of the treatment with lithium salt a compensatory fall in HC03-excretion occurs for one further day. Hence in some sort of way an equilibrium state is produced and maintained as long as lithium salt is given at the same dose. What this compensatory state is important in affecting is still a matter for speculation, as is its nature. Perhaps mitochondria1 binding is involved (see Gear & Lehninger, 1968) .
Within the limits of the method used (Bergmeyer & Bernt, 1963) there is no discernible change of plasma 2-oxoglutarate concentration, nor of plasma alkali reserve (after the administration of lithium salts). Theconsiderably diminished renal clearance of 2-oxoglutarate therefore seems consistent with an inhibition of net tubular reabsorption. The increased excretion of glutarate and of succinate, adipate, fumarate, u-hydroxyglutarate and 2-hydroxy-4-oxoglutarate more recently demonstrated in this Unit (Lee & Pollitt, 1973) after the administration of lithium salts may be seen as consistent with this view. They suggest that structural relationship is more important than 531st MEETING, LANCASTER metabolic relationship. On the other hand, as fumarate, succinate and 2-oxoglutarate are all excreted in increased amounts, but not citrate, pyruvate or lactate, a direct effect of the ion on enzymic processes in the tricarboxylic acid cycle cannot be excluded.
Concomitantly, and in order to explore the effect of treatment with lithium salts on theexcretion of 2-oxoglutaratefurther, P. A. Bond, L. Grant &F. A. Jenner (unpublished work) have studied rats injected with 0.2mmol of the chloride or citrate of Li+ or other ions intraperitoneally. The urine 2-oxoglutarate and citrate were measured in the 3 h before the injection and compared with those in the 3 h after the injection. Rats, like men, show a clear increase of urine 2-oxoglutarate both in absolute amounts and measured as concentrations. Similar injections of the chlorides NaCI, RbCI, CsCI, MnCI2, MgCI2, KCI and SrCI2 do not produce such an increase. There is a small circadian increase, and also sodium citrate causes an increase, possibly due to the alkalotic effect. Mn2+ was too generally toxic to the animals, but the animals' behaviour and general condition were not obviously affected by the other ions. Cs+ and Caz+, and to a smaller extent Rb+, have the opposite effect to Li+, and decrease 2-oxoglutarate excretion after acute administration. Fig. 1 summarizes the results obtained. Under the conditions of the study, only Li+ and Mg2+ appear in the 3 h urine as a significant proportion of the injected material. However, though this might suggest that the effect is bound to the presence of the foreign cation in the urine or kidney, studies involving chronic treatment with Rb+, Cs+ or I 3 in the food until similar urinary excretions are produced does not The possibility that our essentially renal studies might be analogues of more important studies in the nervous system seems t o be increased by the earlier results obtained by Berl &Clarke (1971) and DeFeudis & Delgado (1970) , who both in effect show that Li+ tends to lead to a decrease in brain glutamate. This also highlights the possible relevance of the work of, for example, Wiechert & Knaape (1972) on the cerebral activity of the derivatives of glutamate.
Inhibition of iiasopressiii
By using the preparation described by Bisset (l962), the ethanol-anaesthetized and water-loaded rat for the assay of vasopressin, it was found that L i c k a specificand reversible inhibitor of vasopressin (Harris & Jenner, 19690,h) . Li+ (13mequivJ) was given intravenously in an infusion in which Na+ (13mequiv.jl) was replaced in a modified Czaczkes et al. (1964) solution. Na+, K+, Ca2+, Mg2+, Sr+ and Rb' show similar inhibition when given incomparable amounts. It was, however, also noted that it was necessary to administer continuously the Li+ to sustain the inhibition. The inhibition was quickly reversed, despite high plasma concentrations of Li+, 30min after the administration of Li' had been stopped. This shows clearly that neither the absolute concentrations of whole-body Li+ nor those of plasma Li' are critical for the inhibition, and suggests that the effect depends on the intracellular/extracellular Li+ concentration ratio (Harris & Jenner, 1971~) . It is equally noteworthy that, though Rb+ and Sr+ d o not affect the action of vasopressin when being administered, they d o seem to increase the sensitivity of the preparation when one stops giving them (Harris & Jenner, 1972) , perhaps when they are leaving the 'cells'.
The production of a vasopressin-resistant diabetes-insipidus-like state by treatment with lithium salts is well recognized both clinically (Angrist et al., 1970) and in rats (Schou, 1958; Thomsen, 1970) . Whether our results are relevant to this is at least open to question, as clinically it follows chronic administration, but possibly occurs when the hypothalamus can no longer compensate for the renal inhibition. However, our own preliminary results in nian d o not show a rise in vasopressin excretion after treatment with lithium salts.
Inhibition of adenylate cyclase has been suggested as a possible explanation of the inhibition of vasopressin produced by treatment with lithium salts (Dousa & Hechter, 1970; Forn & Valdecasas, 1971) . Harris & Jenner (19716) have, however, shown that Li+ inhibits the water transport facilitated by cyclic AMP as well as that facilitated by vasopressin. Both in the rat kidney and in the toad bladder Li+ also inhibits the vasopressin-like effects on water of oxytocin (Harris & Jenner, 1972) .
In further work in this Unit with toad bladders, Li+ at 2mequiv./l (E. A. Thompson, unpublished work) did not inhibit Na+ transport facilitated by vasopressin measured as the short-circuit current, nor did it affect the resting potential difference. At higher concentrations (10mequiv./l) the short-circuit current is profoundly lowered. This might suggest that the important therapeutic action could be unrelated to effects on Na".
The study of the inhibition of vasopressin by treatment with lithium salts requires further study. Goodwin & Jenner (1967) have shown that the antidiuretic activity of urine can change with changing mood in periodic psychosis. Vasopressin also has a behavioural effect, a t least in rats, as it decreases the rate of extinction of conditioned avoidance learning (De Wied, 1969) . Preliminary studies show that lithium salts, far from inhibiting this effect, act like vasopressin in the rat, but also cause a n increase in serum vasopressin concentration (E. A. Thompson & D . De Wied, unpublished work). In the rat this could be due to the hypothalamic compensation for the renal inhibition, but a direct effect of Li+ on the hypothalamus also seems likely, and is supported for the drinking centres of the lateral hypothalamus by the result obtained by Smith et al. (1971) .
Distrihirtiorz of ctrtioris in the hotly
The administration of lithium salts is clearly the cause of multiple disturbances and interactions with the distribution of ions other than Li+ is in particular to be expected. Birch (1971) has shown that in rats given lithium salts in their drinking fluid (8mequiv. of Li+/l) or injected intraperitoneally daily with 0.2mequiv. of Li+ as the citrate or chloride for 28 days there is a decrease in brain Na+ and Mg2+, bone Na+ and Ca2+ and urine K+ and Na+; at the same time there is an increase in muscle Ca2+, plasma Mg2 ' , urine volume and renal Ca2+ excretion. Li+ itself is specially concentrated in bone.
Hullin e f al. (1968) had already shown that there is a positive Li' balance for some time in patients treated with Li2C03. After the treatment had ceased, they showed episodes of Li+ excretion still occurring. This might be explained, at least in part, by some laying down of Li+ in bone.
Electroencephalogvaphic studies
In studies on the electroencephalograms of human subjects, we have found amplitude increases and slowing of the frequencies seen in sonie persons as a consequence of treatment with lithium salts (see also Helmchen & Kanowski, 1971 ) that can persist for up to 5 weeks after its administration has been discontinued (see Fig. 2 ). On simply decreasing the dose the electroencephalographic changes have occasionally been found to be a good early indication of impending relapse (see Hanna eta/., 1972) . If these electroencephalographic changes are very directly related to the therapeutic effect of treatment with lithium salts, their timing would suggest that many of the other factors studied in our work may be fairly irrelevant to therapy. However, much more work is required to explore the implications of these and other people's studies.
Discussion
The above alone might warn us against trying to fit all the effects of treatment with lithium salts into one hierarchy of events. However, the clear interactions between carbohydrate metabolism, Mg2+ and Ca2+, and the importance of the latter for the action of vasopressin, give some grounds for speculation. Li+ has a valency and charge like that of Na+ and K+, but an ionic potential like that of Ca2+ and an ionic radius like that of Mg2+ (see Birch, 1970) . Carbohydrate metabolism is affected, and clinically this can be shown by the increased mean blood glucose concentrations after treatment with lithium salts and increased concentrations in glucose tolerance tests (Shopsin et al., 1972) . Li+ might do this by stimulating the effect of hexokinase (Balan et al., 1970) , and this may be related to the increased glucose uptake of tissues after treatment with lithium salts (Bhattacharya, 1959) .
Li+ also inhibits pyruvate kinase (Balan et al., 1970) , but our failure to detect any change in the urinary excretion of pyruvate, lactate and citrate in man, despite clear changes in that of other tricarboxylic acid-cycle metabolites, suggests this might be only causing a comparatively minor disturbance. The inhibition by Li+ of protein kinase (Walaas et al., 1970) also seems remote from our findings. The field is well reviewed by Mellerup et a/. (1973) , which group has also shown that LiCl injections in rats cause an increase of a radioimmunoassayable glucagon-like substance in plasma (Mellerup et a/., 1970) . Although these authors say this is a peripheral effect, it could be of central importance. They have subsequently also shown that there is an increase in serum insulin concentration after treatment with lithium, and this is possibly secondary to the glucagon rise (E. T. Mellerup, H. Grmland Thomsen, N. Bjorum & 0. J. Rafaelsen, personal communication), which they suggest may be related to the increases in body weight described by Kerry e f al. (1970) in patients treated with lithium salts. This increase in body weight due to the accumulation of fat may have to be distinguished from changes in the volume of body water also occurring in these situations. 
